HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?

Discrepancies have been reported between HER2 status in primary breast cancer and micrometastatic cells in bone marrow. The aim of this study was to assess HER2 gene status in micrometastatic cells in bone marrow and corresponding primary tumour. Micrometastatic cells were detected in bone marrow as...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Vincent-Salomon, A, Pierga, J-Y, Couturier, J, d'Enghien, C D, Nos, C, Sigal-Zafrani, B, Lae, M, Fréneaux, P, Diéras, V, Thiéry, J-P, Sastre-Garau, X
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2007
Gaiak:
Genetics and Genomics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360046/
https://ncbi.nlm.nih.gov/pubmed/17262082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603584
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak